|
1
|
Kitchens WH, Uehara S, Chase CM, Colvin
RB, Russell PS and Madsen JC: The changing role of natural killer
cells in solid organ rejection and tolerance. Transplantation.
81:811–817. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pratschke J, Stauch D and Kotsch K: Role
of NK and NKT cells in solid organ transplantation. Transpl Int.
22:859–868. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
López-Botet M, Vilches C, Redondo-Pachón
D, Muntasell A, Pupuleku A, Yélamos J, Pascual J and Crespo M: Dual
role of natural killer cells on graft rejection and control of
cytomegalovirus infection in renal transplantation. Front Immunol.
8:1662017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu G, Xu X, Vu MD, Kilpatrick ED and Li
XC: NK cells promote transplant tolerance by killing donor
antigen-presenting cells. J Exp Med. 203:1851–1858. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Michel T, Poli A, Cuapio A, Briquemont B,
Iserentant G, Ollert M and Zimmer J: Human CD56bright NK cells: An
update. J Immunol. 196:2923–2931. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Crespo M, Yelamos J, Redondo D, Muntasell
A, Perez-Saéz MJ, López-Montañés M, García C, Torio A, Mir M,
Hernández JJ, et al: Circulating NK-cell subsets in renal allograft
recipients with anti-HLA donor-specific antibodies. Am J
Transplant. 15:806–814. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Assadiasl S, Sepanjnia A, Aghili B, Nafar
M, Ahmadpoor P, Pourrezagholi F, Parvin M, Shahlaee A, Nicknam MH
and Amirzargar A: Natural killer cell subsets and IL-2, IL-15 and
IL-18 genes expressions in chronic kidney allograft dysfunction and
graft function in kidney allograft recipients. Int J Organ
Transplant Med. 7:212–217. 2016.PubMed/NCBI
|
|
8
|
Carrega P, Bonaccorsi I, Di Carlo E,
Morandi B, Paul P, Rizzello V, Cipollone G, Navarra G, Mingari MC,
Moretta L and Ferlazzo G: CD56(bright)perforin(low) noncytotoxic
human NK cells are abundant in both healthy and neoplastic solid
tissues and recirculate to secondary lymphoid organs via afferent
lymph. J Immunol. 192:3805–3815. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Melsen JE, Lugthart G, Lankester AC and
Schilham MW: Human circulating and tissue-resident CD56 (bright)
natural killer cell populations. Front Immunol. 7:2622016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shin S, Kim YH, Cho YM, Park Y, Han S,
Choi BH, Choi JY and Han DJ: Interpreting CD56+ and CD163+
infiltrates in early versus late renal transplant biopsies. Am J
Nephrol. 41:362–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hongo D, Tang X, Dutt S, Nador RG and
Strober S: Interactions between NKT cells and Tregs are required
for tolerance to combined bone marrow and organ transplants. Blood.
119:1581–1589. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang X, Kojo S, Harada M, Ohkohchi N,
Taniguchi M and Seino KI: Mechanism of NKT cell-mediated transplant
tolerance. Am J Transplant. 7:1482–1490. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Godfrey DI, MacDonald HR, Kronenberg M,
Smyth MJ and Van Kaer L: NKT cells: What's in a name. Nat Rev
Immunol. 4:231–237. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng LS, Mao FY, Zhao YL, Wang TT, Chen N,
Zhang JY, Cheng P, Li WH, Lv YP, Teng YS, et al: Altered phenotypic
and functional characteristics of CD3+CD56+ NKT-like cells in human
gastric cancer. Oncotarget. 7:55222–55230. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Golden-Mason L, Castelblanco N, O'Farrelly
C and Rosen HR: Phenotypic and functional changes of cytotoxic
CD56pos natural T cells determine outcome of acute hepatitis C
virus infection. J Virol. 81:9292–9298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diao H, He J, Zheng Q, Chen J, Cui G, Wei
Y, Ye P, Kohanawa M and Li L: A possible role for NKT-like cells in
patients with chronic hepatitis B during telbivudine treatment.
Immunol Lett. 160:65–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Haas M, Sis B, Racusen LC, Solez K, Glotz
D, Colvin RB, Castro MC, David DS, David-Neto E, Bagnasco SM, et
al: Banff 2013 meeting report: Inclusion of c4d-negative
antibody-mediated rejection and antibody-associated arterial
lesions. Am J Transplant. 14:272–283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haas M, Loupy A, Lefaucheur C, Roufosse C,
Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E,
et al: The banff 2017 kidney meeting report: Revised diagnostic
criteria for chronic active T cell-mediated rejection,
antibody-mediated rejection and prospects for integrative endpoints
for next-generation clinical trials. Am J Transplant. 18:293–307.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fehniger TA, Shah MH, Turner MJ, VanDeusen
JB, Whitman SP, Cooper MA, Suzuki K, Wechser M, Goodsaid F and
Caligiuri MA: Differential cytokine and chemokine gene expression
by human NK cells following activation with IL-18 or IL-15 in
combination with IL-12: Implications for the innate immune
response. J Immunol. 162:4511–4520. 1999.PubMed/NCBI
|
|
20
|
Márquez ME, Millet C, Stekman H, Conesa A,
Deglesne PA, Toro F, Sanctis JD and Blanca I: CD16 cross-linking
induces increased expression of CD56 and production of IL-12 in
peripheral NK cells. Cell Immunol. 264:86–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bendelac A, Savage PB and Teyton L: The
biology of NKT cells. Annu Rev Immunol. 25:297–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin SJ, Huang YC, Cheng PJ, Lee PT, Hsiao
HS and Kuo ML: Interleukin-15 enhances the expansion and function
of natural killer T cells from adult peripheral and umbilical cord
blood. Cytokine. 76:348–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu X, Huang H, Wang Q, Cai M, Qian Y, Han
Y, Wang X, Gao Y, Yuan M, Xu L, et al: IFN-γ-producing Th1-like
regulatory T cells may limit acute cellular renal allograft
rejection: Paradoxical post-transplantation effects of IFN-γ.
Immunobiology. 222:280–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Poli A, Michel T, Thérésine M, Andrès E,
Hentges F and Zimmer J: CD56bright natural killer (NK) cells: An
important NK cell subset. Immunology. 126:458–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu X, Huang H, Cai M, Qian Y, Li Z, Bai H,
Han Y, Xiao L, Zhou W, Wang X and Shi B: Combination of IL-1
receptor antagonist, IL-20 and CD40 ligand for the prediction of
acute cellular renal allograft rejection. J Clin Immunol.
33:280–287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cassano P, Bui E, Rogers AH, Walton ZE,
Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah
A, et al: Inflammatory cytokines in major depressive disorder: A
case-control study. Aust N Z J Psychiatry. 51:23–31. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Curran-Everett D: Multiple comparisons:
Philosophies and illustrations. Am J Physiol Regul Integr Comp
Physiol. 279:R1–R8. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maghazachi AA: Role of chemokines in the
biology of natural killer cells. Curr Top Microbiol Immunol.
341:37–58. 2010.PubMed/NCBI
|
|
29
|
Zhou HL, Wang YT, Gao T, Wang WG and Wang
YS: Distribution and expression of fibroblast-specific protein
chemokine CCL21 and chemokine receptor CCR7 in renal allografts.
Transplant Proc. 45:538–545. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang H, Xu X, Yao C, Cai M, Qian Y, Wang
X and Shi B: Serum levels of CXCR3 ligands predict T cell-mediated
acute rejection after kidney transplantation. Mol Med Rep. 9:45–50.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Oh K, Kim S, Park SH, Gu H, Roopenian D,
Chung DH, Kim YS and Lee DS: Direct regulatory role of NKT cells in
allogeneic graft survival is dependent on the quantitative strength
of antigenicity. J Immunol. 174:2030–2036. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang SH, Jin JZ, Lee SH, Park H, Kim CH,
Lee DS, Kim S, Chung NH and Kim YS: Role of NKT cells in allogeneic
islet graft survival. Clin Immunol. 124:258–266. 2007. View Article : Google Scholar : PubMed/NCBI
|
